NFA
PLSE icon

Nationwide Fund Advisors’s Pulse Biosciences PLSE Stock Holding History

Nationwide Fund Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,126
Closed -$95K – 1550
2017
Q3 		$95K Hold
5,126
– – ﹤0.01% 2921
2017
Q2 		$177K Buy
+5,126
New +$141K ﹤0.01% 2675

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nationwide Fund Advisors's PLSE Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Pulse Biosciences (PLSE) in Q4 2017, closing a stake of 5,126 shares — an estimated $95K sold.

Nationwide Fund Advisors first reported a position in PLSE in Q2 2017 and held it in 2 quarters. The position peaked at $177K in Q2 2017. 50 funds tracked by Wall St. Rank hold PLSE as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Pulse Biosciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,126 Pulse Biosciences shares in Q4 2017, an estimated $95K.
  • Nationwide Fund Advisors first reported a position in Pulse Biosciences in Q2 2017 and held it in 2 quarters.
  • Nationwide Fund Advisors's Pulse Biosciences position peaked at $177K in Q2 2017.
  • 50 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.